InMode Ltd.
InMode Ltd. (INMD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INMD · as of Jun 8, 2026
Key Statistics
Explore InMode Ltd. Data
inmd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 45.5%
The INMD analyst consensus is Hold, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $17.00, representing +25.55% upside from the current price of $13.54.
Competitors & Peers
inmd competitorsINMD
AHCO
ANAB
AXGN
CTEV
IARTStock Performance
Full HistoryAbout InMode Ltd.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofre…
what is inmode ltd. · inmd stock overview · inmode ltd. company profile · who is inmode ltd. ceo · inmd NASDAQ · inmode ltd. headquarters · inmode ltd. business segments
About Stock Overview & Key Data
InMode Ltd. (INMD) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Aug 8, 2019. As of the latest trading session, INMD stock price is $13.54, with a market capitalization of $823.4M. The stock has returned -7.01% over the past 12 months and -7.83% year-to-date.
According to 11 Wall Street analysts, the consensus rating for InMode Ltd. stock is Hold, with an average 12-month price target of $17.00. In fiscal year 2025, InMode Ltd. reported revenue of $370.5M and net income of $93.8M. For detailed data — including InMode Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, InMode Ltd. (INMD) stock price is $13.54. The stock is traded on NASDAQ under the ticker symbol INMD. The 52-week range is $12.72 – $16.74.